Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Endogenous steroid hormone, estriol precursor; ...
ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...
Pyridopyrimidinone; PI3K and mTOR inhibitor.
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...
Mycotoxin produced by Penicillum and Aspergillu...
Cysteine adduct inducer, PARP-1 inhibitor.
NSAID; COX-1/2 inhibitor.
Kavalactone originally found in Piper methystic...
EGFR inhibitor.
Nucleoside (thymidine) analog; DNA chain termin...
Kavalactone originally found in Piper methystic...
RF-amide peptide; potential GPR147 agonist, pot...
Found in Capsicum; TRPV agonist.
Glycosaminoglycan
Pentacyclic triterpene found in various plant s...
Flavone found in Passiflora, Oroxylum, and Pleu...
Peptide, derivative of AT I, cleavage product o...
H+/K+ ATPase and Scpc phosphatase inhibitor.
Phase II enzyme inducer; Nrf2 activator; antiox...
Unlikely to reverse Alzheimer’s